Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 10962224)

1.

Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia.

Purdon SE, Flor-Henry P.

Schizophr Res. 2000 Sep 1;44(3):221-32.

PMID:
10962224
2.

Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.

Woolley JD, Lam O, Chuang B, Ford JM, Mathalon DH, Vinogradov S.

Psychoneuroendocrinology. 2015 Mar;53:217-22. doi: 10.1016/j.psyneuen.2014.12.018. Epub 2015 Jan 7.

PMID:
25637811
3.

Olfactory function and morphology of olfactory epithelium in an adult population with schizophrenia.

Minovi A, Dombrowski T, Brüne M, Dazert S, Juckel G.

Schizophr Res. 2015 Feb;161(2-3):513-4. doi: 10.1016/j.schres.2014.11.023. Epub 2014 Dec 4. No abstract available.

PMID:
25481344
4.

Olfactory perception in schizophrenia: the rating range for hedonic judgements is increased during acute episodes.

Clepce M, Reich K, Gossler A, Kornhuber J, Thuerauf N.

Psychiatry Res. 2013 Jun 30;208(1):81-3. doi: 10.1016/j.psychres.2012.09.052. Epub 2012 Oct 22.

PMID:
23089162
5.

Evaluation of smoking on olfactory thresholds of phenyl ethyl alcohol and n-butanol.

Hayes JE, Jinks AL.

Physiol Behav. 2012 Sep 10;107(2):177-80. doi: 10.1016/j.physbeh.2012.06.020. Epub 2012 Jul 6.

PMID:
22776624
6.

Olfaction and cognition in schizophrenia: sex matters.

Malaspina D, Keller A, Antonius D, Messinger JW, Goetz DM, Harkavy-Friedman J, Goetz RR, Harlap S.

J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):165-75. doi: 10.1176/appi.neuropsych.11070154.

PMID:
22772664
7.

Olfaction, "olfiction," and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity.

Cohen AS, Brown LA, Auster TL.

Schizophr Res. 2012 Mar;135(1-3):152-7. doi: 10.1016/j.schres.2011.12.005. Epub 2012 Jan 12.

PMID:
22244185
8.

A preliminary investigation of olfactory function in olfactory and auditory-verbal hallucinators with schizophrenia, and normal controls.

Stevenson RJ, Langdon R.

Cogn Neuropsychiatry. 2012;17(4):315-33. doi: 10.1080/13546805.2011.633748. Epub 2011 Dec 19.

PMID:
22181045
9.

Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study.

Reden J, Herting B, Lill K, Kern R, Hummel T.

Laryngoscope. 2011 Mar;121(3):679-82. doi: 10.1002/lary.21401. Epub 2011 Feb 1.

PMID:
21287560
10.

Olfactory sensitivity: functioning in schizophrenia and implications for understanding the nature and progression of psychosis.

Brewer WJ, Pantelis C.

Vitam Horm. 2010;83:305-29. doi: 10.1016/S0083-6729(10)83013-4. Review.

PMID:
20831952
11.

Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements.

Nguyen AD, Shenton ME, Levitt JJ.

Harv Rev Psychiatry. 2010 Sep-Oct;18(5):279-92. doi: 10.3109/10673229.2010.511060. Review.

PMID:
20825265
12.

Olfactory reference syndrome: a systematic review of the world literature.

Begum M, McKenna PJ.

Psychol Med. 2011 Mar;41(3):453-61. doi: 10.1017/S0033291710001091. Epub 2010 Jun 9. Review.

PMID:
20529415
13.

Reduced laterality as a trait marker of schizophrenia--evidence from structural and functional neuroimaging.

Oertel V, Knöchel C, Rotarska-Jagiela A, Schönmeyer R, Lindner M, van de Ven V, Haenschel C, Uhlhaas P, Maurer K, Linden DE.

J Neurosci. 2010 Feb 10;30(6):2289-99. doi: 10.1523/JNEUROSCI.4575-09.2010.

14.

Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.

Hong X, Chan RC, Zhuang X, Jiang T, Wan X, Wang J, Xiao B, Zhou H, Jiang L, Weng B.

Schizophr Res. 2009 Mar;108(1-3):151-7. doi: 10.1016/j.schres.2008.11.016. Epub 2008 Dec 23.

PMID:
19106034
15.

Neuroleptic-induced parkinsonism is associated with olfactory dysfunction.

Krüger S, Haehner A, Thiem C, Hummel T.

J Neurol. 2008 Oct;255(10):1574-9. doi: 10.1007/s00415-008-0993-5. Epub 2008 Sep 3.

PMID:
18769856
16.

Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).

Baier PC, Weinhold SL, Huth V, Gottwald B, Ferstl R, Hinze-Selch D.

Brain. 2008 Oct;131(Pt 10):2734-41. doi: 10.1093/brain/awn193. Epub 2008 Aug 21.

17.

Reduced cortical inhibition in first-episode schizophrenia.

Wobrock T, Schneider M, Kadovic D, Schneider-Axmann T, Ecker UK, Retz W, Rösler M, Falkai P.

Schizophr Res. 2008 Oct;105(1-3):252-61. doi: 10.1016/j.schres.2008.06.001. Epub 2008 Jul 14.

PMID:
18625547
18.

Olfactory physiological impairment in first-degree relatives of schizophrenia patients.

Turetsky BI, Kohler CG, Gur RE, Moberg PJ.

Schizophr Res. 2008 Jul;102(1-3):220-9. doi: 10.1016/j.schres.2008.03.013. Epub 2008 May 5.

19.

Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300.

Higuchi Y, Sumiyoshi T, Kawasaki Y, Matsui M, Arai H, Kurachi M.

Schizophr Res. 2008 Apr;101(1-3):320-30. doi: 10.1016/j.schres.2008.01.020. Epub 2008 Mar 5.

PMID:
18321680
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk